Efficacy in the central nervous system (CNS) of two combination regimens with different penetration rank in HIV-positive naive patients

Trial Profile

Efficacy in the central nervous system (CNS) of two combination regimens with different penetration rank in HIV-positive naive patients

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Mar 2012

At a glance

  • Drugs Abacavir (Primary) ; Lopinavir/ritonavir (Primary) ; Atazanavir; Emtricitabine/tenofovir disoproxil fumarate; Ritonavir
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top